LFSC

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change +0.07
Percentage change 0.30	%

Category	US Equities - Factor & Thematic	Asset Type	Equities (Stocks)	Tags	Developed	Return% 1Y	-	Shs Outstand		Perf Week	1.65%
Sponsor	F/m Investments	ETF Type		Tags	equity	Return% 3Y	-	Total Holdings	32	Perf Month	11.75%
Fund Family		Bond Type		Tags	innovation	Return% 5Y	-	AUM	51.60M	Perf Quarter	-10.29%
Index	-	Average Maturity		Tags	healthcare	Return% 10Y		NAV%		Perf Half Y	-9.69%
Index Weighting		Commodity Type		Tags	biotechnology	Return% SI		NAV/sh		Perf Year	-
Active/Passive		Quant Type		Tags	medical	Flows% 1M	0.00%	52W Range	18.78 - 27.76	Perf YTD	-1.16%
Dividend TTM	-	ESG Type		Tags	pharmaceutical	Flows% 3M	5.50%	52W High	-16.71%	Beta	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	7.85%	52W Low	23.11%	ATR (14)	0.49
Expense	0.54%	Structure Type		Region		Flows% 1Y		RSI (14)	55.84	Volatility	0.90% 1.64%
Option/Short	No / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.00	Prev Close	23.05
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	4.13K	Price	23.12
SMA20	3.19%	SMA50	3.07%	SMA200	-4.33%	Trades		Volume	4	Change	0.30%

Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

F/m Emerald Life Sciences Innovation ETF

Upgrade your FINVIZ experience